Month: November 2011

Alliance between Almirall and BioFocus to identify new compounds directed against therapeutic targets.

|

Alliance between Almirall and BioFocus to identify new compounds against targets therapeutic.


-these therapeutic targets are related to the treatment of respiratory and inflammatory diseases

Barcelona, November 2011- Almirall, S.A. and BioFocus announce the signing of a collaboration agreement to move forward in the search for new molecules directed against relevant targets of interest for Almirall. These molecules are used to support projects aimed at the treatment of respiratory and inflammatory diseases.

Under the agreement, BioFocus apply their screening technologies and their collections of compounds to the projects that has underway Almirall.

Dr. Bertil Lindmark, Executive Director of r & d of Almirall, asserts that “ we have been impressed by the advanced technology employed by BioFocus, as well as the experience of the scientists involved in the projects. Therefore, we are convinced that this agreement leverage our internal resources and this will allow us to accelerate our research programmes of new drugs for the treatment of respiratory and inflammatory diseases ”.

Dr. Kate Hilyard, Vice President of biological sciences of BioFocus, stresses that “ this drug discovery partnership with one of the main companies of pharmaceutical research at European level is of great interest to us. ”

Almirall

Almirall is an international pharmaceutical company based on innovation and committed to health. With headquarters in Barcelona (Spain), Almirall researches, develops, produces and sells drugs own r & d and licensing with the aim of improving the health and well-being of people.

The therapeutic areas in which concentrates its resources in research are related to the treatment of asthma, COPD (chronic obstructive pulmonary disease), gastrointestinal disorders, psoriasis and other skin complaints forms.

Almirall drugs are currently present in over 70 countries. It has direct presence in Europe and Latin America through 12 subsidiaries.

BioFocus

BioFocus provides drug discovery solutions through a comprehensive platform led by specialized equipment with a career in the discovery of candidate genes to clinic. BioFocus offers the discovery of objectives in human primary cells, libraries of compounds both focused as diverse, so screening medical in vitro as based on cells, structural biology, chemistry and ADME/PK supported by tools services quimiogenómicas and unique computer. As the Services Division of the Galapagos, BioFocus now has 210 employees with facilities for research in three countries.

BioFocus ® is a trademark of Galapagos NV and/or its subsidiaries.

Read More

The Prince of Asturias Hospital Conference on atopic dermatitis.

|

Conference of the Prince of Asturias Hospital on dermatitis atopic.

the activities of the week’s science.

Madrid, November 2011- The Prince of Asturias Hospital organized a Conference on atopic dermatitis, a disorder characterized by intense itching and dry skin. The Conference was held last Friday 18 at the Faculty of Medicine of the University of Alcalá, with free and open access. Atopic dermatitis is of hereditary genetic disease whose symptoms can be associated to other manifestations such as asthma or allergy rinoconjuntivales.

Critical injury of atopic dermatitis is eczema, more prevalent in childhood, that appears in the first months of life to manifest themselves in the so-called “ outbreak of infant ”, which can be acute, generalized or centered in the folds of arms, elbows, knees and face.

As there is the development of the baby, atopic dermatitis usually focus on the areas of flexura. For adults, the lesions are more localized. Although the disease curse by outbreaks, the skin of patients, whether children or adults, need hydration of permanently, dryness is the main feature of this pathology.

The fall and winter are more complicated stations for these patients, as they increase the symptoms. In spring and summer decreases because the Sun has a stabilizing function. Outbreaks may be triggered by stress and associated diseases that weaken the body. Severe atopic dermatitis needs general treatment with oral medications that alleviate the intense itching and swelling.

Self-care of the skin

Skin care is essential to reduce skin aggression involving this pathology: the shower instead of bathing, it is recommended not to rub the skin, use extrahidratantes soaps and body lotions after showering, choose clothing with a high percentage of cotton and not use colony (due to the alcoholic basis and perfume containing the colonies and can penetrate in) (the skin of the patient generating allergies).

The Dermatology service of the Prince of Asturias University Hospital annually serves nearly 500 patients (between children and adults) affected by this dermatological disease, either mild manifestations or with outbreaks severe.

This Conference is enmarccó in the activities of the Science week organized by the General Directorate of universities and research of the Ministry of education and employment of the Of Madrid and was held last Friday 18 at 10: 00 in the Faculty of Medicine of the University of Alcalá.

Read More

PGA and the Spanish society of hospital pharmacy recall the importance of properly following drug treatments.

|

The AGP and the Spanish society of hospital pharmacy remind of the importance of correctly follow treatment-pharmacological.

November 15, the day of adherence and medication information.

-la adherence Therapeutics is a priority health problem that affects, on the one hand, to the treatment of the disease and, on the other hand, the sustainability of the health care system

-The services of pharmacy of more than one hundred hospitals in all Spain joined in this initiative of informative character and disseminated various materials such as leaflets and posters

– “ there is a pharmacist in your hospital can help! ” is the motto of the campaign “ knows the importance of taking its pharmacological treatment correctly? ”, which stresses the importance of the pharmacist in the therapeutic bond

Madrid, 2011-November on the occasion of the celebration of the day of adherence and drug information, which was held last Tuesday 15, the General Alliance of patients supports the campaign “ knows the importance of taking its pharmacological treatment correctly? ” led by the Spanish society of hospital pharmacy (Spanish) to through its foundation and the Government Council and has the endorsement of the Ministry of health, Social policy and equality.

“ La adherence Therapeutics is a priority health issue because it affects both the sustainability of the health system and the treatment of the disease ”, indicated from the Spanish, an argument that also supports the Organization World of health.

Two years by raising the population

The day of adherence and and drugs information aims to raise awareness and explain the importance of a good adherence to drug therapy to the patient. In this second edition of the day, through the campaign “ knows the importance of taking its pharmacological treatment correctly? ” and under the motto “ there is a pharmacist at the hospital. can help you! ” the pharmacy services from more than 100 hospitals in all Spain will disseminate this initiative through leaflets and posters and inform the population of three key aspects:

-the patient is responsible for his treatment.

-the patient must be informed of the drug to receive.

-hospital pharmacist is the person in charge of giving This information.

Always close to the patient

In addition, a new feature this year has opened participation to all patients, as the central focus of activity and daily commitment of the Spanish. In this way, you can enter the web page www.sefh.es/dia-adherencia and fill a small test to find out how much you know about your medications and receive information about the use of treatments at the same time.

do knew what…?do do do

– a consequence of not having adequate information on medicines is the abandonment of the treatment?

– abandon treatment or take it wrong can lead to a therapeutic failure?

– a therapeutic failure can have important consequences for health?

-treatment failure is a major problem of public health with an enormous economic impact?

on the General Alliance of patients

La General patients Alliance (CPA) includes entities and Spanish sanitary institutions in various fields. It has been created with the intention of promoting the dialogue of patient organisations with the health administrations, professionals in the same area and private entities.

The main mission of the PGA is to provide patient organisations of mechanisms for participation in healthcare decisions. To this end, PGA seeks to facilitate dialogue between health professionals, public administrations, private health sector companies and organizations themselves of patients, sharing objectives, improvement opportunities and problems to solve.

PGA is constituted as a platform for dialogue around patients, using criteria of quality and transparency.

Read More

The SinDOLOR platform announces the 3rd Edition of its awards for journalism.

|

The platform SinDOLOR announces the 3rd Edition of their journalism awards.


– may participate the journalistic work published or broadcast in 2011, the deadline for submission of nominations began last Tuesday, November 15 and ends on February 29, 2012

-the best works in the categories of General media, specialized press and audiovisual media receive a prize of € 5,000 each one and a commemorative sculpture

– summons the SinDOLOR platforman initiative of the Grünenthal Foundation and the Foundation for research in health (FUINSA), and counts on the collaboration of the National Association of health informers (ANIS)

Madrid, November of 2011- the platform SinDOLOR announces the 3rd Edition of its awards for journalism. These awards, with the collaboration of ANIS, are aimed at recognizing the best journalistic works that have contributed most to educate Spanish society about the problem of pain, your diagnosis, evolution and treatment.

It will be awarded a prize of 5,000 euros, more a Memorial sculpture, to the best article or report presented in each of the three categories of the contest: General media, specialized press and audiovisual media. In total, the awards are endowed with 15,000 euros. In addition, ten finalists works and their authors will be disseminated in the media of communication.

A jury made up of personalities from medicine and journalism, will choose the winning entries valuing their content, rigour, language and creativity. This year the jury is composed by: Dr. D. Alberto Camba, Chairman of the SED (Spanish society of pain); DRA. Ms. Dolors Navarro, Vice-President of the Spanish forums of patients; D. Francisco Cañizares, President of ANIS (National Association of health informers); D. José Manuel González Huesa, CEO of Servimedia; D. Jaume Segalés, director and presenter of weekend players in ABC – point Radio; D. Norberto Villarrasa, director of the Grünenthal Foundation; Dr. D. Anton Herreros, director of FUINSA (Foundation for health research); and D. Juan Quintana, which will be the Secretary of the jury of the III Edition of the awards of journalism platform SinDOLOR.

since Tuesday, November 15 and until February 29, 2012, may submit journalistic work published or aired in written press, radio, television or Internet between January 1 and December 31, 2011both inclusive, have as main theme pain from medical, social, socio-economic point of view or disclosure. Likewise, the author or authors shall be holders of the papers presented and communication professionals.

Candidates, media or institutions wishing to participate can consult the contest rules, as well as download the form for registration at web http://www.plataformasindolor.com.

About platform SinDOLOR

The SinDOLOR platform is an initiative launched in October 2008 by FUINSA (Foundation for health research) and the Grünenthal Foundation with the aim of improving care for the patient with pain and their families. The SinDOLOR platform aims to raise awareness of health structures and society on the importance of pain for those who suffers from, coordinating actions of training, research and patient care initiatives to improve the current situation.

Read More

November 21, celebrated the international day of spina bifida.

|

The 21 November celebrated the international day of spina bifida.

Madrid, November 2011- La Spina Bifida (EB) or Myelomeningocele (as it is scientifically called) is the congenital malformation serious, compatible with life.

According to recent studies, if all women in childbearing age consume 0.4 mg of folic acid at least 3 months before getting pregnant and during the first trimester of pregnancy, could reduce the likelihood that his son was born with EB up to 70%.

The Spanish Federation of associations of spina bifida and Hydrocephalus (FEBHI), Member entity of COCEMFE , celebrated the international day of spina bifida, a date which is for people affected by EB, a reminder to the society of his situation and the needs that have to be on equal footing with other citizens because of the consequences that entails the malformed and the high cost involved in healthcare products and orthopedic.

Therefore, the Federated associations held meetings and various acts of awareness by all Spain.

the past Wednesday, November 16 at 11: 00 started the prevention campaign, carried out by the health centres in all Spain, with the punch of the first poster in the center of health City Garden of Madrid. The event counted with the participation of Javier Fernández-Lasquetty, Director of health of the community of Madrid, Carmen Gil, President of FEBHI; Paula Rivero, Vice-President of AMEB (Madrid Association for Spina bifida); and Maria de Los Angeles Jaime, Director of the health centre where took place.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips